We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

BIOBANK Renal Transplantation University Hospitals Leuven

This study is currently recruiting participants.
Verified May 2016 by Prof Dr Maarten Naesens, Universitaire Ziekenhuizen Leuven
Sponsor:
ClinicalTrials.gov Identifier:
NCT01331668
First Posted: April 8, 2011
Last Update Posted: May 11, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Prof Dr Maarten Naesens, Universitaire Ziekenhuizen Leuven
April 6, 2011
April 8, 2011
May 11, 2016
March 2004
December 2099   (Final data collection date for primary outcome measure)
Renal allograft survival [ Time Frame: 50 years after transplantation ]
Not Provided
Complete list of historical versions of study NCT01331668 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
BIOBANK Renal Transplantation University Hospitals Leuven
Biobank Renal Transplantation University Hospitals Leuven
This study aims to maintain a prospective biobank of human samples obtained from donors and recipients of renal allografts, including biopsy tissue, peripheral blood samples and urine samples.
Clinical data and bio-specimens are prospectively collected and stored for undefined future translational research projects.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Biopsy material (tissue, RNA, DNA) Peripheral blood samples (serum, plasma, RNA, DNA) Urine samples
Probability Sample
All donors and recipients of a kidney transplant at the University Hospitals Leuven
Kidney Failure
Not Provided
renal allograft donors and recipients
All de novo renal allograft recipients transplanted at the University Hospitals Leuven

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
5000
December 2099
December 2099   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • renal transplant recipients/donors

Exclusion Criteria:

Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact: Maarten Naesens, MD, PhD 32 16344580 maarten.naesens@uzleuven.be
Belgium
 
 
NCT01331668
TRA-UZL-BIOBANK-001
No
Not Provided
Not Provided
Prof Dr Maarten Naesens, Universitaire Ziekenhuizen Leuven
Universitaire Ziekenhuizen Leuven
Not Provided
Principal Investigator: Maarten Naesens, MD, PhD University Hospitals Leuven
Universitaire Ziekenhuizen Leuven
May 2016